Global Marine Pharmaceuticals Market Research Report 2020

The drug obtained from marine organisms which are being conventionally used like shark and cod-liver oils, sodium alginate, agar-agar, chitin etc.

Marine organisms are potential source for drug discovery. Life has originated from the oceans that cover over 70% of the surface of earth and contain highly ecological, chemical and biological diversity starting from micro-organisms to vertebrates. This diversity has been the source of unique chemical compounds, which hold tremendous pharmaceutical potential.
North America is the largest consumption market of Marine Pharmaceuticals, with sales market share nearly 33.4% in 2018. The second place is Europe; following North America with the sales market share over 23.3%, China and Japan are also an important sales area. In 2018, The global marine pharmaceuticals market will observe steady growth because of the robust growth in APAC during the forecast period. But, the market shares of the Americas and EMEA will decline to some extent during the forecast period. APAC will be a leader in market growth during the forecast period owing to the increasing awareness and improved access to healthcare.

The global Marine Pharmaceuticals market is valued at 26570 million US$ in 2020 is expected to reach 47330 million US$ by the end of 2026, growing at a CAGR of 8.5% during 2021-2026.
This report focuses on Marine Pharmaceuticals volume and value at the global level, regional level and company level. From a global perspective, this report represents overall Marine Pharmaceuticals market size by analysing historical data and future prospect. Regionally, this report focuses on several key regions: North America, Europe, China and Japan etc.
Market Segment Analysis
The research report includes specific segments by Type and by Application. This study provides information about the sales and revenue during the historic and forecasted period of 2015 to 2026. Understanding the segments helps in identifying the importance of different factors that aid the market growth.
Segment by Type, the Marine Pharmaceuticals market is segmented into
Drugs
Health Supplement

Segment by Application
Hospital & Clinic
Pharmacy
Other

Global Marine Pharmaceuticals Market: Regional Analysis
The Marine Pharmaceuticals market is analysed and market size information is provided by regions (countries). The report includes country-wise and region-wise market size for the period 2015-2026. It also includes market size and forecast by Type and by Application segment in terms of sales and revenue for the period 2015-2026.
The key regions covered in the Marine Pharmaceuticals market report are:
North America
U.S.
Canada
Europe
Germany
France
U.K.
Italy
Russia
Asia-Pacific
China
Japan
South Korea
India
Australia
Taiwan
Indonesia
Thailand
Malaysia
Philippines
Vietnam
Latin America
Mexico
Brazil
Argentina
Middle East & Africa
Turkey
Saudi Arabia
U.A.E
Global Marine Pharmaceuticals Market: Competitive Analysis
This section of the report identifies various key manufacturers of the market. It helps the reader understand the strategies and collaborations that players are focusing on combat competition in the market. The comprehensive report provides a significant microscopic look at the market. The reader can identify the footprints of the manufacturers by knowing about the global revenue of manufacturers, the global price of manufacturers, and sales by manufacturers during the forecast period of 2015 to 2019.
The major players in global Marine Pharmaceuticals market include:
Seattle Genetics
DSM
Eisai Co
Takeda
BASF
Amway
Pfizer
Pelagia (EPAX)
Pharma Mar SA
Croda
GNC
GSK
TerSera Therapeutics
Nordic Naturals
Carlson Labs